Erdheim-Chester disease
3 clinical trialsnone recruiting1 country3 open to children
3 substances studiedView
- 1 country
- Substances:VemurafenibFludeoxyglucose (18F)+1 more
Diseases
Learn more about your disease – page 29
1 684 diseases in the catalogue8 841 linked trialsUpdated today
Top 10 most studied diseases
Diseases with the highest number of active trials right now.
Colours show each disease's body system – lighter shades rank lower.
- Neoplasms benign, malignant and unspecified57%
- Blood and lymphatic system disorders20%
- Gastrointestinal disorders15%
- Metabolism and nutrition disorders8%
No. 1 most studied
Non-small cell lung cancer
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Respiratory, thoracic and mediastinal disorders
326Active trials · 21% of the top 10
- recruiting now
- 107
- countries
- 27
- open to children
- 0
- substances tested
- 245
Shares are of these ten diseases' active trials together.
All diseases
Browse every disease currently studied across European trials.
A–Z
1 684 diseases
Fibromyalgia
3 clinical trialsnone recruiting3 countries
3 substances studiedView
Fibromyalgia
Musculoskeletal and connective tissue disorders
- 3 countries
- Substances:PsilocybineBupivacaine Hydrochloride+1 more
Gastric cancer stage IV
3 clinical trials2 recruiting4 countries
2 substances studiedView
2 recruiting
Gastric cancer stage IV
Gastrointestinal disordersNeoplasms benign, malignant and unspecified (incl cysts and polyps)
- 4 countries
- Substances:Ds-3939AGallium (68Ga) Tezatabep Matraxetan
Glomerulonephritis
3 clinical trialsnone recruiting3 countries
5 substances studiedView
Glomerulonephritis
Immune system disordersRenal and urinary disorders
- 3 countries
- Substances:BelimumabDESMOPRESSIN ACETATE+3 more
Haemophilia A with anti factor VIII
3 clinical trialsnone recruiting12 countries
1 substance studiedView
Haemophilia A with anti factor VIII
Blood and lymphatic system disordersCongenital, familial and genetic disorders
- 12 countries
- Substances:Concizumab
Haemorrhagic stroke
3 clinical trials2 recruiting5 countries
2 substances studiedView
- 5 countries
- Substances:Eptacog Alfa (Activated)Ixodes Ricinus Contact Phase Inhibitor
Hairy cell leukaemia
3 clinical trials1 recruiting7 countries
6 substances studiedView
1 recruiting
Hairy cell leukaemia
Blood and lymphatic system disordersNeoplasms benign, malignant and unspecified (incl cysts and polyps)
- 7 countries
- Substances:CladribineCobimetinib+4 more
Hepatoblastoma
3 clinical trials3 recruiting16 countries1 open to children
16 substances studiedView
3 recruiting1 open to children
Hepatoblastoma
Hepatobiliary disordersNeoplasms benign, malignant and unspecified (incl cysts and polyps)
- 16 countries
- Substances:CarboplatinCisplatin+14 more
Hereditary optic atrophy
3 clinical trials2 recruiting5 countries
2 substances studiedView
- 5 countries
- Substances:Nicotinamide18‐Mer Antisense Oligonucleotide Complementary To Opa1 Pre-Mrna
Hodgkin's disease refractory
3 clinical trials1 recruiting3 countries
5 substances studiedView
1 recruiting
Hodgkin's disease refractory
Blood and lymphatic system disordersNeoplasms benign, malignant and unspecified (incl cysts and polyps)
- 3 countries
- Substances:Brentuximab VedotinHSP-CAR30+3 more
Hyperadrenocorticism
3 clinical trials1 recruiting3 countries
1 substance studiedView
Hyperglycaemia
3 clinical trials1 recruiting2 countries
1 substance studiedView
- 2 countries
- Substances:Insulin Human
Hyperinsulinaemic hypoglycaemia
3 clinical trials1 recruiting9 countries
2 substances studiedView
- 9 countries
- Substances:Anti-(Insulin Receptor) Human Monoclonal AntibodyPasireotide Diaspartate
Hyperinsulinism
3 clinical trials2 recruiting7 countries
3 substances studiedView
- 7 countries
- Substances:DasiglucagonEfpegerglucagon+1 more
Hyperlipidaemia
3 clinical trials1 recruiting7 countries
8 substances studiedView
- 7 countries
- Substances:AlirocumabAtorvastatin+6 more
Hyponatraemia
3 clinical trials1 recruiting3 countries
6 substances studiedView
1 recruiting
Hyponatraemia
Metabolism and nutrition disordersInjury, poisoning and procedural complications
- 3 countries
- Substances:GlucoseGlucose Monohydrate+4 more
Hypoxia
3 clinical trials2 recruiting3 countries
1 substance studiedView
- 3 countries
- Substances:Deferoxamine Mesilate
Inclusion body myositis
3 clinical trials1 recruiting3 countries
2 substances studiedView
1 recruiting
Inclusion body myositis
Immune system disordersMusculoskeletal and connective tissue disorders
- 3 countries
- Substances:RuxolitinibULVIPRUBART
Indolent systemic mastocytosis
3 clinical trials2 recruiting17 countries
3 substances studiedView
2 recruiting
Indolent systemic mastocytosis
Blood and lymphatic system disordersImmune system disorders
- 17 countries
- Substances:Avapritinib1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone+1 more
Infectious pleural effusion
3 clinical trials1 recruiting3 countries
2 substances studiedView
1 recruiting
Infectious pleural effusion
Infections and infestationsRespiratory, thoracic and mediastinal disorders
- 3 countries
- Substances:AlteplaseDornase Alfa
Invasive breast carcinoma
3 clinical trials3 recruiting5 countries
7 substances studiedView
3 recruiting
Invasive breast carcinoma
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Reproductive system and breast disorders
- 5 countries
- Substances:CarboplatinDocetaxel+5 more
Langerhans cell sarcoma
3 clinical trialsnone recruiting1 country3 open to children
3 substances studiedView
- 1 country
- Substances:VemurafenibFludeoxyglucose (18F)+1 more
Langerhans' cell histiocytosis
3 clinical trialsnone recruiting1 country3 open to children
6 substances studiedView
3 open to children
Langerhans' cell histiocytosis
Blood and lymphatic system disordersEndocrine disorders
- 1 country
- Substances:AlemtuzumabIndometacin Ph. Eur.+4 more
Left ventricular dysfunction
3 clinical trials2 recruiting17 countries1 open to children
1 substance studiedView
- 17 countries
- Substances:Vericiguat